The Breast Cancer Research Foundation
BCRF Healthologysend an e-cardsupport our partners

resourcespresscontact usdonate now
about BCRFresearch in actionpartners & programseventsget involved
emailprint

Psoriasis Psoriatic Arthritis

Treating Psoriatic Arthritis with DMARDs


Medically Reviewed On: February 14, 2007

When the symptoms of psoriatic arthritis (PsA) are severe, doctors often turn to disease-modifying antirheumatic drugs (DMARDs) for treatment. These drugs alleviate the symptoms of psoriatic arthritis as well as slow down or stop joint and tissue damage and the progression of the disease.

DMARDs comprise several classes of medications. Traditionally, they are used to either reduce the body’s risk of rejection of a transplanted organ or to treat conditions such as cancer or inflammatory bowel disease. When they are used to treat psoriatic arthritis, the doses are significantly lower and the risk of side effects tends to be considerably less.

The common denominator among all DMARDs is their ability to modify the underlying processes that cause inflammatory conditions such as psoriatic arthritis. They accomplish this feat by altering how the immune system functions. A description of the various types of DMARDs follows.

Chemotherapy Drugs
The most commonly used DMARD is methotrexate. Taken by mouth or injection, it is an immunosuppressive drug approved by the Food and Drug Administration (FDA) for the treatment of psoriasis, but it is also used widely and successfully for treating psoriatic arthritis. Methotrexate has proven effective at relieving the symptoms associated with psoriatic arthritis, and studies suggest it may help prevent joint destruction as well. It works by binding to an enzyme that is involved in the rapid growth of cells. Sometimes it is given in combination with other drugs to alleviate the signs and symptoms of psoriatic arthritis.

Methotexate is usually well tolerated in low doses. However, a number of side effects are associated with it, including the long term potential for liver damage. Regular blood tests are also needed to ensure that the body is tolerating the drug properly and to see if there are any negative effects on the bone marrow or the blood. Methotrexate can lower white blood cell counts, which can make a person more prone to infection.

Antimalaria Medications
Antimalaria drugs, such as hydroxychloroquine (Plaquenil®), are also effective at relieving pain, reducing joint inflammation and decreasing damage to the joints, skin and other organs in the body. Generally, it takes from 8 to 12 weeks for the body to respond.

Page 1 of 2 Next Page >>

RELATED PROGRAMS
Article - What is Psoriatic Arthritis?
Article - Treating Psoriatic Arthritis
Article - The Causes of Psoriasis
Article - Combination Therapy for Psoriasis
HealthVideo.com © 2008 NBC Digital Health Network, Inc. All Rights Reserved
Privacy Policy - Disclaimer - Editorial Policy
We subscribe to the HONcode principles.
HonCode Logo
Verify here

join our mailing listsend an e-cardsupport our partners


homesite mapsearchtermsprivacy policycontact us© 2007 The Breast Cancer Research Foundation